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In Vitro Reconstitution of a Cellular Phase-Transition Process that
Involves the mRNA Decapping Machinery**
Simon A. Fromm, Julia Kamenz, Erik R. Nçldeke, Ancilla Neu, Georg Zocher, and
Remco Sprangers*
Abstract: In eukaryotic cells, components of the 5’ to 3’ mRNA
degradation machinery can undergo a rapid phase transition.
The resulting cytoplasmic foci are referred to as processing
bodies (P-bodies). The molecular details of the self-aggrega-
tion process are, however, largely undetermined. Herein, we
use a bottom-up approach that combines NMR spectroscopy,
isothermal titration calorimetry, X-ray crystallography, and
fluorescence microscopy to probe if mRNA degradation
factors can undergo phase transitions in vitro. We show that
the Schizosaccharomyces pombe Dcp2 mRNA decapping
enzyme, its prime activator Dcp1, and the scaffolding proteins
Edc3 and Pdc1 are sufficient to reconstitute a phase-separation
process. Intermolecular interactions between the Edc3 LSm
domain and at least 10 helical leucine-rich motifs in Dcp2 and
Pdc1 build the core of the interaction network. We show that
blocking of these interactions interferes with the clustering
behavior, both in vitro and in vivo.
Processing bodies (P-bodies) are cytoplasmic micrometer-
scale ribonucleoprotein (RNP) foci that were initially iden-
tified in mammalian cells[1] and that have now been observed
in distant branches of eukaryotes. The list of proteins that are
found in these mRNP granules has grown significantly[2] and
comprises general mRNA decay factors including the Dcp2
decapping enzyme and the enhancers of decapping Dcp1,
Edc3, Pat1, and LSm1–7.[1c,3] The proposed roles of the
clustering of the decapping enzyme within a confined cellular
space includes enhanced substrate binding,[4] buffering of the
concentration of translating mRNAs,[5] regulation of the
concentrations of free cytoplasmic proteins,[6] and a means to
respond to cellular stress.[7]
The details of the interactions that underlie the self-
assembly process of proteins and RNA into P-bodies are
largely undetermined. Genetic studies have addressed the
importance of individual proteins[8] and revealed two major
characteristics. 1) the details of the intermolecular interac-
tions vary among species. For example, Edc3 and the Q/N rich
C-terminal region of LSm4 can act as a scaffold for P-body
assembly in S. cerevisiae,[3c,9] whereas the Pdc1 protein has
been shown to be important in S. pombe.[10] 2) the P-body
assembly process is highly redundant and deletion of a single
protein does not abolish the aggregation process completely.[8]
This redundancy complicates genetic approaches that aim to
identify the interactions that regulate the self-assembly
process.
Recently, it was shown that the purified Nck and N-WASP
proteins can undergo a phase transition in vitro.[11] These
experiments are in line with the idea that the formation of
cellular granules relies on a network of multivalent weak
interactions between different components.[6, 12] Herein, we
ask whether it is possible to reconstitute a phase-transition
process with proteins that have been shown to localize to P-
bodies. To that end, we focus on the purified S. pombe Dcp2
mRNA decapping enzyme, its prime activator Dcp1 and the
scaffolding proteins Edc3 and Pdc1 and show that these
proteins can spontaneously self-assemble into oil-like drop-
lets.
The proteins Edc3 and Dcp2 (Figure 1 A) have been
shown to interact through contacts between the Edc3 LSm
domain and short helical leucine-rich motifs (HLMs) in
Dcp2.[13] Herein, we use NMR spectroscopy titration experi-
ments and show that Dcp2 contains at least seven different
HLMs that are recognized specifically by the Edc3 LSm
domain (Figure 1B). Interestingly, the extent of the observed
chemical shift changes varies, indicating that the HLM
affinities vary considerably. To quantify these, we used
isothermal titration calorimetric (ITC) assays (Figure 1C,D)
and find that the Edc3:HLM affinities range from (2.5
0.3) mm to the mm range.
A prerequisite for protein phase separation is the
capability to associate into indefinite soluble assemblies. In
general, this condition is fulfilled for multivalent proteins with
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independent binding sites. Theoretically, Edc3 and Dcp2 can
form such an indefinite and highly branched network of
interactions because Edc3 is a dimer (and thus contains two
LSm domains) and Dcp2 contains seven Edc3 docking sites
(Figure S1 A in the Supporting Information). In addition, the
binding affinities in the Edc3:Dcp2 system range from low mm
to mm which has been suggested to be beneficial for the
generation of phase transitions.[6] To address if the Edc3:Dcp2
network is suitable to induce a phase separation in vitro, we
mixed the recombinantly expressed and purified far C-
terminal region of Dcp2 that contains four HLMs (Dcp2
residues 553–741; Table S1 A) with full-length Edc3. Interest-
ingly, a clear phase separation can be observed using a bright-
field microscope (Figure 2A, left). Both Edc3 and Dcp2 are
significantly enriched within the droplet-like structures as
judged from the fluorescent signal that resulted from the
Oregon green labeled proteins (Figure 2A, and Figures S1 B,
S1 C). Our data thus shows that the network of interactions
between Edc3 and Dcp2 is suffi-
cient to induce phase separations.
To obtain insights into the
conditions that result in phase
separation we varied the concen-
trations of Edc3 and the part of
Dcp2 that contains 4 HLMs (Fig-
ure 2 B, left). We observed that
phase separation occurs when
a number of conditions are met.
First, the absolute concentration
of the individual proteins needs to
be sufficiently high. In case a cer-
tain threshold concentration is
not exceeded, phase separation
does not take place and the
proteins remain homogeneously
distributed in solution. Second,
the molar ratio of the two pro-
teins needs to be within specific
limits. In case the excess of either
of the two proteins is too large,
phase separation is abolished.
This occurrence can be explained
by the fact that a large excess of
Edc3 would result in a situation
where all HLMs are bound to
a dimeric Edc3 protein, which
would result in a loss of intertwin-
ing between different Dcp2
chains. A large excess of Dcp2
would, on the other hand, result
in a situation where there are
insufficient dimeric Edc3 proteins
available to link the Dcp2 chains.
In a second set of experi-
ments, we determined if the
number of intermolecular inter-
actions between components
influences the phase-separation
process. As full length Dcp2 that
comprises seven HLMs was not expressed stably in our hands,
we designed a version of Dcp2 that contains the complete
unfolded C-terminal region but that lacks a part of the
proline-rich region. This Dcp2 C-term DMid protein (Dcp2
residues 242–289 + 553–741; Supporting Information
TableS1 A) contains five HLMs and undergoes phase tran-
sitions at concentrations that are significantly lower than
those required for the Dcp2 construct that contains four
HLMs. As an example: in the presence of 150 mm Edc3 phase
separation takes place when the Dcp2 C-term DMid (five
HLMs) concentration is 25 mm (125 mm modular HLM con-
centration), whereas double the concentration of the Dcp2-
fragment that contains four HLMs (50 mm ; 200 mm modular
HLM concentration) is required. In agreement with previous
observations,[11] we can thus conclude that the valency and
affinities of the interacting partners determines whether
phase separation occurs at specific concentrations. Impor-
tantly, as controls we performed experiments using either
Figure 1. The seven HLMs in Dcp2 bind to the Edc3 LSm domain with a wide range of affinities.
A) Schematic representation of S. pombe Dcp1 (EVH1 domain, yellow), Dcp2 (regulatory light green,
catalytic dark green, HLMs red, proline-rich mid domain white, C-terminus gray) and Edc3 (LSm dark
blue, FDF motif orange, YjeF N light blue). All used protein constructs are listed in Supporting
Information Table S1A. B) 1H–15N correlation spectra of the binding between the monomeric Edc3 LSm
domain and the seven isolated Dcp2 HLMs. Black: free 15N labeled Edc3 LSm domain, Red: the Edc3
LSm domain in the presence of a fivefold excess of the individual Dcp2 HLMs. The boxed region in the
top left panel is shown in all other spectra. Residues R38 and L58 are highlighted with ovals to indicate
that the HLMs induce chemical shift perturbations to a different extent. C) ITC graphs for the binding
of the Edc3 LSm domain to the Dcp2 HLM-1, HLM-C1 and HLM-C2 sequences. The best fit is drawn
with a red line and the extracted Kd values including the error (standard deviation) are indicated.
Deviations from n = 1.0, where n refers to the stoichiometry, result from small inaccuracies in the
protein-concentration determination. D) Overview of the determined Kd values (error in parenthesis) for
the Dcp2 HLM:Edc3 interactions (n.d.: not determinable with ITC).
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a monomeric version of Edc3 or a Dcp2 sequence that only
contains a single HLM (Figure S1 D,E). In none of these
control experiments we observed phase separation (Fig-
ure S1D,E), as the valency of one of the components is
reduced to one.
Cellular foci, including P-bodies, have been shown to be
highly dynamic.[14] To determine if the in vitro Edc3:Dcp2
phase separations that we prepared from purified compo-
nents display a similar behavior we monitored the droplets
over a longer time. We observed a number of fusion events
that confirm the liquid-like behavior of the in vitro droplets
(Figure 2C). This underscores that the in vitro system is
similar to the in vivo situation regarding this aspect.
In vivo, the foci that contain Dcp2 and Edc3 also comprise
numerous additional proteins. To test if it is possible to recruit
additional proteins within the reconstituted in vitro droplets,
we extended the Dcp2 C-term DMid construct such that it
also includes the Dcp2 catalytic and the regulatory domain
(Dcp2 DMid, residues 1–289 + 553–741; Table S1A) that has
been shown to interact with Dcp1.[15] We then mixed purified
Dcp1:Dcp2 complexes that harbored five HLM sequences
with Edc3 and observed a clear phase separation, indicating
that the Edc3:Dcp2 droplets can recruit additional factors
(Figure 2D). It should be noted that Dcp1 contains the
binding site for Xrn1,[16] thereby providing a mechanism to
recruit the exonuclease to the Dcp1:Dcp2:Edc3 assemblies. In
addition, the Edc3 protein contains an FDF repeat, providing
a means to recruit the helicase DDX6/Dhh1.[17] The catalytic
domain of Dcp2[18] and the helicase can then provide binding
sites for mRNA substrates.
The Edc3:HLM interactions form the core of the in vitro
droplets we assemble. Interference with this interaction is
thus expected to result in the loss of
phase separation. To test this hypoth-
esis, we supplemented the Dcp2:Edc3
droplet conditions with the HLM-
1 sequence (Figure 1D). With
increasing amounts of the HLM-
1 Dcp2 peptide, we observe a disap-
pearance of the phase separation
in vitro (Figure 2E). To assess the
consequences of the specific interfer-
ence with the Edc3:HLM interaction
for P-body formation in vivo, we
overexpressed the HLM-1 peptide
in S. pombe. To observe the recruit-
ment of Edc3 to P-bodies we replaced
the edc3 + gene at its endogenous
locus by the edc3 +-mCherry fusion
construct. To simultaneously assess
P-body integrity we additionally
fused Dcp2 or Lsm7 to GFP at their
endogenous loci. In cells that did not
express the peptide that interferes
with the Edc3:HLM interaction we
observed P-bodies that contain Edc3-
mCherry and Dcp2-GFP or Lsm7-
GFP, respectively (Figure 3A,B, top
rows). On the other hand, in cells that
overexpress the HLM peptide the Edc3-mCherry protein is
no longer recruited into P-bodies (Figure 3A,B, bottom
Figure 2. In vitro phase transitions of purified Edc3 and Dcp2. A) Phase transition of 50 mm Dcp2
553-741 and 150 mm Edc3 (doped 1:100 with Edc3-OregonGreen). Left: bright field (BF) channel;
middle: Oregon Green (OG) channel; right: merge. B) Phase diagrams of phase transition of Edc3
together with Dcp2 553–741 (that contains 4 HLM sequences; left) or Dcp2 242–741DMID (that
contains 5 HLM sequences). Given concentrations are modular concentrations, for example, 50 mm
of Dcp2 553–741 is 200 mm HLMs, because 4 HLMs are in the Dcp2 553–741 construct. Modular
LSm concentration is identical with total Edc3 concentration as an Edc3 monomer has one LSm
domain. Occurrence of phase transition at a given condition is color coded; blue = no phase
transition; light blue= beginning phase transition; green= clear phase transition. Green lines
indicate progression of the phase boundaries. The red encircled condition is shown in (A) and (C).
C) The in vitro droplets are highly dynamic and fuse over time. The time-scale is indicated below
the OG channel pictures. D) Droplets formed by 25 mm Dcp1:Dcp2DMID and 100 mm Edc3 (doped
1:100 with Edc3-OG). Left: BF channel, Right: OG channel. E) Droplets formed by 25 mm Dcp2
242–741DMID and 100 mm Edc3 disappear by addition of increasing amounts of Dcp2 242–291
(containing HLM-1) (5 mm, 10 mm, 25 mm, 50 mm). Scale bars: 50 mm.
Figure 3. Effect of HLM-1 expression on Edc3 localization in vivo. A,B)
Fluorescent micrographs of S. pombe expressing mCherry and GFP
tagged versions of Edc3 and Dcp2 (A) or Lsm7 (B), respectively.
Without HLM-1 overexpression Edc3 and Dcp2 are enriched into P-
bodies (top row). Upon overexpression (adh1 promoter) of HLM-
1 Edc3 no longer localizes to P-bodies but is diffusely spread in the
cell (bottom row). Dcp2-GFP (A) and Lsm7 (B) still localize to P-
bodies upon overexpression of HLM-1, indicating that interference
with the Edc3:HLM interactions does not generally disturb P-body
formation. Scale bar: 5 mm.
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rows). This lack of recruitment is most likely a consequence of
the Edc3 LSm domains that are now saturated with the
overexpressed mono-valent peptide. These in vivo observa-
tions are in agreement with our in vitro phase separation.
Importantly, the overexpression of the HLM competition
peptide does not result in the general loss of P-bodies as both
Dcp2-GFP and Lsm7-GFP are still found in distinct cellular
foci (Figure 3A,B, middle panels, bottom rows). These
observations stress the fact that in vivo P-body formation is
a highly redundant process, where the loss of one P-body
component does not result in a general loss of these foci.
To obtain insights into the redundancy of P-body forma-
tion, we turned to the Pdc1 protein that was recently
implicated in P-body integrity in S. pombe.[10] Pdc1 is related
to metazoan Edc4 (Ge-1, Hedls)[19] and both proteins contain
an N-terminal WD-40 domain and a central coiled-coil region
(Figure 4A). Close inspection of the protein sequence at the
N-terminal region of the S. pombe Pdc1 protein indicates the
presence of several HLMs (Figure 4A). Using NMR titration
experiments (Figure 4B) we confirmed that the N-terminal
region of Pdc1 contains at least three HLM sequences that
can interact with the Edc3 LSm domain. The extent of the
induced chemical shift perturbations in the Edc3 LSm domain
varied between the Pdc1 HLMs, as was the case for the seven
Dcp2 HLMs (Figure 1B, 4B). Using ITC experiments, we
quantified the associated affinities and found that the three
Pdc1 HLM sequences interact with the Edc3 LSm domain
between 150 mm and lower mM range (Figure 4C,D). Inter-
estingly, the Pdc1 protein contains a central coiled-coil region,
through which the protein can oligomerize, resulting in an
increased number of HLMs in the biological unit of the
protein. Above, we have shown that a large number of HLMs
is favorable for the phase separation process (Figure 2B). To
test whether Edc3 and Pdc1 are able to induce phase
transitions in vitro we initially tried to purify the Pdc1 protein
from E. coli. Unfortunately, full-length Pdc1 was, in our
hands, not stable enough to allow for in vitro phase separation
experiments. Consequently, we engineered a Pdc1 protein
where the coiled-coil region was replaced with glutathione S-
transferase (GST). GST is a dimer in solution and thus mimics
the oligomerization effect of the Pdc1 coiled-coil region. We
then used this designed dimeric Pdc1 protein (that has an
HLM valency of six) and the dimeric Edc3 protein (that has
an LSm valency of two) to test whether Pdc1 and Edc3 can
undergo phase transitions in vitro. Interestingly, we observe
that Pdc1 and Edc3 are able to engage in an indefinite
network of intermolecular interaction that results in the
formation of an oil-like droplet phase (Figure 4E), as we
observed for Dcp2 and Edc3 (Figure 2 A). We can thus
conclude from our in vitro experiments that Pdc1 and Dcp2
are redundant proteins with regard to the potential of
inducing phase separation when mixed together with Edc3.
Sequence alignments of the C-terminal region of the
S. pombe Pdc1 protein with the C-terminal regions of the
human, D. melanogaster and A. thaliana Edc4 proteins sug-
gest the presence of a Ge-1C domain
[20] in the Pdc1 protein,
although the sequence identity (17 %) is very low (Fig-
ure S2A). To confirm the presence of a Ge-1C domain in
Pdc1, we solved the crystal structure of residues 932 to 1076 to
a resolution of 1.35  (PDB code: 4Q2S; Table S2). The
structure displays a closely packed helical bundle, where the
three N-terminal helices make an approximate 90-degree
angle with the five C-terminal helices (Figure 5A). The
structure of the domain is very similar to the known structure
of the Ge-1C region of the D. melanogaster Ge-1 protein
(Figure S2 B).
Previously, it was shown that the C-terminal 290 residues
of Pdc1 interact with Dcp2.[10] To probe if this interaction is
direct, we performed NMR chemical shift titration experi-
ments with the 15N labeled Pdc1 Ge-1C domain and an
unlabeled Dcp1:Dcp2 decapping complex (Dcp2 residues 1–
95). We observe that resonance signals from residues that are
located in the C-terminal helices of the Pdc1 Ge-1C domain
are significantly perturbed (Figure 5B). This result indicates
that Pdc1 exploits a surface at the far C-terminus of the
protein to directly contact the Dcp1:Dcp2 decapping complex
(Figure 5A). Pdc1 can thus interact with Edc3 through
a number of HLMs at its far N-terminal region and with the
decapping complex through the Ge-1c domain at its far C-
terminal region. These results underscore the scaffolding
Figure 4. Pdc1 contains three HLMs at the N-terminus that bind to
Edc3 with different affinities. A) Domain organization of the Pdc1
protein (N-terminal HLMs cyan, WD40 repeats purple, coiled-coil or-
ange, Ge-1C-like domain (see below) pink). B)
1H–15N correlation
spectra of the monomeric 15N labeled Edc3 LSm domain in the
absence (black) and presence (cyan) of the individual Pdc1 HLMs. The
boxed region in the top left panel of Figure 1B is shown, ovals
highlight two specific residues (see above). C) ITC graph of the Edc3
LSm domain binding to HLM-N2 from Pdc1. The best fit is drawn
with a cyan line and the extracted Kd value is indicated. D) Overview of
all Kd values (error in parentheses) determined for binding of Pdc1
HLMs to Edc3 LSm (n.d., not determinable with ITC). E) In vitro
phase separation of designed dimeric Pdc1 construct that mimics full
length Pdc1 (50 mm) together with Edc3 (150 mm ; doped 1:100 with
Edc3-OregonGreen). Scale bar, 50 mm.
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function of Pdc1 and explain its importance for processing
body formation. Addition of Pdc1 to Edc3 and Dcp2 (Fig-
ure 2B) is thus expected to increase the strength of the
interaction network, which is advantageous for the phase
transitions process.
We have shown that it is possible to reproduce the in vivo
phase separation behavior of the mRNA degradation machi-
nery in a well-defined in vitro setting. Importantly, this
bottom-up approach provides insights into the clustering
behavior that could not have been obtained using genetic
approaches owing to the highly redundant nature of the
clustering process (Figure 5C,D).
Additional mechanisms that promote the self-aggregation
process of the mRNA degradation machinery will be
exploited in the cell. These additional interactions will be
able to lower the critical concentration required for phase
separation to biologically relevant levels. In that regard, it is
worth mentioning that it was recently shown that low
complexity (LC) regions in the RNA binding protein FUS
are able to induce phase transitions.[6,12, 21] Mechanistically, the
LC regions aggregate through a mechanism that involves the
formation of amyloid-like fibers, a feature that we did not
detect in our current studies. This suggests that both processes
that lead to phase separation are of a fundamentally different
nature. Interestingly, short LC regions are also present in
Dcp2 and Pdc1 and in other S. pombe processing body
proteins, including LSm4, Pat1p, Sum2 (Scd6), Ste13 (Dhh1),
and Exo2 (Xrn1).[22] Future experiments will be able to shed
light on how these LC regions, the HLM:Edc3 interactions
and other specific intermolecular
contacts (Figure 5 C) modulate the
phase-transition process that
underlies P-body formation (Fig-
ure 5D). It has been suggested
that biological systems might
have evolved such that specific
proteins are close to the phase
separation conditions.[6] Minor
modifications in the valency and
the affinity of the interacting part-
ners by post-translational modifi-
cations or small changes in protein
levels can then result in the sudden
appearance or disappearance of
cellular phase separation.[23] Inter-
estingly, the HLM rich region of
Pdc1 contains a large number of
phosphorylation sites[24] that could
potentially interfere with Edc3
binding and reduce the tightness
of the intermolecular interaction
network.
Our results form a starting
point for future in vitro studies
that address how the activity of
the cellular enzymes can be influ-
enced by local cellular molecular
crowding. In addition, we antici-
pate that in vitro approaches sim-
ilar to the one described herein can be exploited to address
how other cellular granules are formed and how specific
proteins are targeted to a specific class of granules.
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